{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T17:37:43Z","timestamp":1760204263894},"reference-count":23,"publisher":"BMJ","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart"],"published-print":{"date-parts":[[1983,12,1]]},"DOI":"10.1136\/hrt.50.6.579","type":"journal-article","created":{"date-parts":[[2007,9,18]],"date-time":"2007-09-18T21:46:00Z","timestamp":1190151960000},"page":"579-585","source":"Crossref","is-referenced-by-count":23,"title":["Haemodynamic response to intravenous hydralazine in patients with pulmonary hypertension."],"prefix":"10.1136","volume":"50","author":[{"given":"M D","family":"McGoon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J B","family":"Seward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R E","family":"Vlietstra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M H","family":"Choo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T P","family":"Moyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G S","family":"Reeder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0002-8703(63)90011-5","article-title":"The hemodynamic effects of isoproterenol on pulmonary hypertension in man","volume":"65","author":"TD, Jr, Lee; GC, Roveti; RS, Ross","year":"1963","unstructured":"Lee TD Jr, Roveti GC, Ross RS. The hemodynamic effects of isoproterenol on pulmonary hypertension in man. Am Heart J 1963; 65: 361-7.","journal-title":"Am Heart J"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0022-5223(19)40113-X","article-title":"The effects of dopamine and isoproterenol on the pulmonary circulation","volume":"71","author":"RM, Jr, Mentzer; CA, Alegre; SP, Nolan","year":"1976","unstructured":"Mentzer RM Jr, Alegre CA, Nolan SP. The effects of dopamine and isoproterenol on the pulmonary circulation. J Thorac Cardiovasc Surg 1976; 71: 807-14.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref_3","first-page":"14145","article-title":"Primary pulmonary hypertension: favorable effects of isoproterenol","volume":"295","author":"Shettigar, U.R.; Hultgren, H.N.; Specter, M.; Martin, R.; Davies, D.H.","year":"1976","unstructured":"Shettigar UR, Hultgren HN, Specter M, Martin R, Davies DH. Primary pulmonary hypertension: favorable effects of isoproterenol. N EnglJ Med 1976; 295: 14145.","journal-title":"N EnglJ Med"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0002-9149(78)90102-9","article-title":"Isoproterenol as a potential pulmonary vasodilator in primary pulmonary hypertension","volume":"42","author":"Daoud, F.S.; Reeves, J.T.; Kelly, D.B.","year":"1978","unstructured":"Daoud FS, Reeves JT, Kelly DB. Isoproterenol as a potential pulmonary vasodilator in primary pulmonary hypertension. Am J Cardiol 1978; 42: 817-22.","journal-title":"Am J Cardiol"},{"key":"ref_5","first-page":"424","article-title":"Effects of tolazoline hydrochloride (Priscoline) on circulatory dynamics of patients with pulmonary hypertension. Am HeartJ'","volume":"55","author":"Rudolph, A.M.; Paul, M.H.; Sommer, L.S.; Nadas, A.S.","year":"1958","unstructured":"Rudolph AM, Paul MH, Sommer LS, Nadas AS. Effects of tolazoline hydrochloride (Priscoline) on circulatory dynamics of patients with pulmonary hypertension. Am HeartJ' 1958; 55: 424-32."},{"issue":"40","key":"ref_6","first-page":"583","article-title":"Primary pulmonary hypertension in a child: response to pharmacologic agents","volume":"1969","author":"Rao, B.N.S.; Moller, J.H.; Edwards, J.E.","unstructured":"Rao BNS, Moller JH, Edwards JE. Primary pulmonary hypertension in a child: response to pharmacologic agents. Circulation 1969; 40: 583-7.","journal-title":"Circulation"},{"key":"ref_7","first-page":"686","article-title":"Primary pulmonary hypertension","volume":"11","author":"Dresdale, D.T.; Schultz, M.; Michtom, R.J.","year":"1951","unstructured":"Dresdale DT, Schultz M, Michtom RJ. Primary pulmonary hypertension. I. Clinical and hemodynamic study. AmJMed 1951; 11: 686-705.","journal-title":"I. Clinical and hemodynamic study. AmJMed"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"772","DOI":"10.7326\/0003-4819-90-5-772","article-title":"Primary pulmonary hypertension treated with oral phentolamine","volume":"90","author":"Ruskin, J.N.; AM, Jr, Hutter","year":"1979","unstructured":"Ruskin JN, Hutter AM Jr. Primary pulmonary hypertension treated with oral phentolamine. Ann Intern Med 1979; 90: 772-4.","journal-title":"Ann Intern Med"},{"key":"ref_9","first-page":"299","article-title":"Verapamil and pulmonary hypertension","volume":"204","year":"1978","unstructured":"Landmark K, Refsum AM, Simonsen S, Storstein 0. Verapamil and pulmonary hypertension. Acta Med Scand 1978; 204: 299-302.","journal-title":"Acta Med Scand"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1136\/hrt.44.3.352","article-title":"Primary pulmonary hypertension: effects of nifedipine","volume":"44","author":"Camerini, F.; Alberti, E.; Klugmann, S.; Salvi, A.","year":"1980","unstructured":"Camerini F, Alberti E, Klugmann S, Salvi A. Primary pulmonary hypertension: effects of nifedipine. Br Heart J 1980; 44: 352-6.","journal-title":"Br Heart J"},{"key":"ref_11","first-page":"572","article-title":"Diazoxide in treatment of primary pulmonary hypertension","volume":"40","author":"Wang, S.W.S.; Pohl, J.E.F.; Rowlands, D.J.; Wade, E.G.","year":"1978","unstructured":"Wang SWS, Pohl JEF, Rowlands DJ, Wade EG. Diazoxide in treatment of primary pulmonary hypertension. Br Heart7 1978; 40: 572-4."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1136\/thx.35.4.269","article-title":"Clinical and haemodynamic effects of diazoxide in primary pulmonary hypertension","volume":"35","author":"Honey, M.; Cotter, L.; Davies, N.; Denison, D.","year":"1980","unstructured":"Honey M, Cotter L, Davies N, Denison D. Clinical and haemodynamic effects of diazoxide in primary pulmonary hypertension. Thorax 1980; 35: 269-76.","journal-title":"Thorax"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1056\/NEJM198001103020204","article-title":"Diazoxide in primary pulmonary hypertension","volume":"302","author":"Klinke, W.P.; Gilbert, J.A.L.","year":"1980","unstructured":"Klinke WP, Gilbert JAL. Diazoxide in primary pulmonary hypertension. N Engl J7 Med 1980; 302: 91-2.","journal-title":"N Engl J7 Med"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/cpt1979255part1541","article-title":"Effects of isosorbide dinitrate on pulmonary hypertension in chronic obstructive pulmonary disease","volume":"25","author":"Danahy, D.T.; Tobis, J.M.; Aronow, W.S.; Chetty, K.; Glauser, F.","year":"1979","unstructured":"Danahy DT, Tobis JM, Aronow WS, Chetty K, Glauser F. Effects of isosorbide dinitrate on pulmonary hypertension in chronic obstructive pulmonary disease. Clin Pharmacol Ther 1979; 25: 541-8.","journal-title":"Clin Pharmacol Ther"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1136\/hrt.40.12.1397","article-title":"Effects of prostaglandin El on pulmonary circulation in patients with pulmonary hypertension","volume":"40","author":"Szczeklik, J.; Dubiel, J.S.; Mysik, M.; Pyzik, Z.; Krol, R.; Horzela, T.","year":"1978","unstructured":"Szczeklik J, Dubiel JS, Mysik M, Pyzik Z, Krol R, Horzela T. Effects of prostaglandin El on pulmonary circulation in patients with pulmonary hypertension. Br HeartJ 1978; 40: 1397-1401.","journal-title":"Br HeartJ"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1056\/NEJM198001103020201","article-title":"Oral hydralazine therapy for primary pulmonary hypertension","volume":"302","author":"Rubin, L.J.; Peter, R.H.","year":"1980","unstructured":"Rubin LJ, Peter RH. Oral hydralazine therapy for primary pulmonary hypertension. N Engi J Med 1980; 302: 69-73.","journal-title":"N Engi J Med"},{"key":"ref_17","first-page":"116","article-title":"Hemodynamics at rest and during exercise after oral hydralazine in patients with cor pulmonale","volume":"47","author":"Rubin, L.J.; Peter, R.H.","year":"1981","unstructured":"Rubin LJ, Peter RH. Hemodynamics at rest and during exercise after oral hydralazine in patients with cor pulmonale. AmJ7 Cardiol 1981; 47: 116-22."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1161\/01.CIR.65.4.645","article-title":"The role of hydralazine therapy for pulmonary arterial hypertension of unknown cause","volume":"65","author":"Lupi-Herrera, E.; Sandoval, J.; Seoane, M.; Bialostozky, D.","year":"1982","unstructured":"Lupi-Herrera E, Sandoval J, Seoane M, Bialostozky D. The role of hydralazine therapy for pulmonary arterial hypertension of unknown cause. Circulation 1982; 65: 645-50.","journal-title":"Circulation"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1172\/JCI110012","article-title":"Influence of prostaglandin synthesis inhibitors on pulmonary vasodilatory effects of hydralazine in dogs with hypoxic pulmonary vasoconstriction","volume":"67","author":"Rubin, L.J.; Lazar, J.D.","year":"1981","unstructured":"Rubin LJ, Lazar JD. Influence of prostaglandin synthesis inhibitors on pulmonary vasodilatory effects of hydralazine in dogs with hypoxic pulmonary vasoconstriction. Clin Invest 1981; 67: 193-200.","journal-title":"Clin Invest"},{"key":"ref_20","first-page":"272","article-title":"Captopril as treatment for patients with pulmonary hypertension: problem of variability in assessing chronic drug treatment","volume-title":"Br Heart","volume":"48","author":"Rich, S.; Martinez, J.; Lam, W.; Rosen, K.M.","year":"1982","unstructured":"Rich S, Martinez J, Lam W, Rosen KM. Captopril as treatment for patients with pulmonary hypertension: problem of variability in assessing chronic drug treatment. Br Heart 1982; 48: 272-7."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0378-4347(00)81145-7","article-title":"Selective highperformance liquid chromatographic assays for hydralazine and its metabolites in plasma of man","volume":"181","author":"Reece, P.A.; Cozamanis, I.; Zacest, R.","year":"1980","unstructured":"Reece PA, Cozamanis I, Zacest R. Selective highperformance liquid chromatographic assays for hydralazine and its metabolites in plasma of man. Chromatogr 1980; 181: 427-40.","journal-title":"Chromatogr"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1056\/NEJM198206033062203","article-title":"Deleterious effects of hydralazine in patients with pulmonary hypertension","volume":"306","author":"Packer, M.; Greenberg, B.; Massie, B.; Dash, H.","year":"1982","unstructured":"Packer M, Greenberg B, Massie B, Dash H. Deleterious effects of hydralazine in patients with pulmonary hypertension. N Engl7 Med 1982; 306: 1326-31.","journal-title":"N Engl7 Med"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1161\/01.CIR.65.7.1369","article-title":"The effects of oral hydralazine on right ventricular end-diastolic pressure in patients with right ventricular failure","volume":"65","author":"Rubin, L.J.; Handel, F.; Peter, R.H.","year":"1982","unstructured":"Rubin LJ, Handel F, Peter RH. The effects of oral hydralazine on right ventricular end-diastolic pressure in patients with right ventricular failure. Circulation 1982; 65: 1369-73.","journal-title":"Circulation"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/hrt.50.6.579","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T00:57:36Z","timestamp":1601081856000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/hrt.50.6.579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1983,12,1]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1983,12,1]]}},"URL":"https:\/\/doi.org\/10.1136\/hrt.50.6.579","relation":{},"ISSN":["1355-6037"],"issn-type":[{"value":"1355-6037","type":"print"}],"subject":[],"published":{"date-parts":[[1983,12,1]]}}}